Osteonecrosis of the jaw related to bevacizumab

J Clin Oncol. 2008 Aug 20;26(24):4037-8. doi: 10.1200/JCO.2007.15.5424.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / adverse effects*
  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology
  • Carcinoma, Ductal, Breast / drug therapy
  • Carcinoma, Ductal, Breast / pathology
  • Female
  • Humans
  • Jaw Diseases / chemically induced*
  • Middle Aged
  • Osteonecrosis / chemically induced*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab